This Biotech Yo-Yos After FDA Panel Recommends Glaucoma Drug [Investor's Business Daily]
Aerie Pharmaceuticals, Inc. (AERI)
Last aerie pharmaceuticals, inc. earnings: 2/20 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.aeriepharma.com/investor-relations
Company Research
Source: Investors Business Daily
Technology Related news 10/12/2017 A Relative Strength Rating upgrade for Aerie Pharmaceuticals shows improving technical performance. A Drug Sent This Biotech To A Fresh High — But There's A Caveat Stocks Showing Rising Market Leadership: Aerie Pharmaceuticals Earns 82 RS Rating Aerie Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold Aerie Pharmaceuticals Sees IBD RS Rating Climb To 73 Aerie Tumbles Ahead Of FDA Panel Review Of Glaucoma Drug Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC Which Four Biotechs Are Derisked, Buyable Ahead of Election Day? Aerie Pharma Dips On 'Minor' Glaucoma Setback And Q3 Miss A split Food and Drug Administration committee voted Friday to recommend approval for Aerie Pharmaceuticals ' ( AERI ) glaucoma drug Rhopressa — sending the company's stock yo-yoing after it was briefly halted in early trades. X Autoplay: On | Off In afternoon trading on the st
Show less
Read more
Impact Snapshot
Event Time:
AERI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AERI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AERI alerts
High impacting Aerie Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics